Study is comparing nano-bio fusion gingival gel and gumloc gel to control redness of gums in patients undergoing fixed orthodontic treatment

Not Applicable

Conditions: Health Condition 1: B998- Other infectious disease

Registration Number: CTRI/2023/07/055108

Lead Sponsor: Dr Khushboo Purohit

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: ot Yet Recruiting

Sex: Not specified

Target Recruitment: 0

Inclusion Criteria

Patients with fixed orthodontic treatment-induced gingivitis aged between 15 and 40 years,

1) Systematically healthy patient with no co morbid history such as rheumatic fever, blood dyscrasias, congenital heart disease or diabetes mellitus

2) Subjects with gingivitis with moderate inflammation (stage 2) assessed by bleeding index, plaque index score >= 2 when checked by periodontal probe.

3) Patients who do not have any other gingival disease like hyperplasia.

Exclusion Criteria

1) patients on antibiotics or anti-inflammatory in the last 30 days,

2) patients who are taking anticonvulsants, antihypertensive or any immunosuppressive drugs

3) pregnant or lactating patients,

4) patients with removable or fixed dental prosthesis,

5) patients having parafunctional habits,

6) patients who have multiple missing teeth,

7) periodontally compromised patients.

8) Patients having habit of smoking and Tobacco or Arecanut

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To evaluate the changes in plaque index (PI), papillary bleeding gingival <br/ ><br>index (PBI) & probing depth (PD) scores following application of <br/ ><br>NBFG gel & Gumloc gel at different time intervalsTimepoint: at baseline, after 7,29,90 days

Secondary Outcome Measures